Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ambrx Biopharma Inc.

    NYSE: AMAM · Real-Time Price · USD
    28.00
    0.02 (0.07%)
    At close: Mar 06, 2024, 10:00 PM

    Ambrx Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.61M 170.06M
    Short-Term Investments
    		 28.87M n/a
    Long-Term Investments
    		 16.79M n/a
    Other Long-Term Assets
    		 339K 530K
    Receivables
    		 2.05M 1.34M
    Inventory
    		 3.73M 5.17M
    Other Current Assets
    		 319K 230K
    Total Current Assets
    		 90.58M 176.81M
    Property-Plant & Equipment
    		 14.01M 15.72M
    Goodwill & Intangibles
    		 25.25M 35.96M
    Total Long-Term Assets
    		 56.39M 52.21M
    Total Assets
    		 146.98M 229.02M
    Account Payables
    		 3.21M 5.27M
    Deferred Revenue
    		 407K 4.27M
    Short-Term Debt
    		 1.73M 915K
    Other Current Liabilities
    		 11.31M 14.13M
    Total Current Liabilities
    		 16.66M 24.58M
    Long-Term Debt
    		 10.24M 12.21M
    Other Long-Term Liabilities
    		 n/a n/a
    Total Long-Term Liabilities
    		 12.47M 14.47M
    Total Liabilities
    		 29.13M 39.05M
    Total Debt
    		 11.98M 13.13M
    Common Stock
    		 27K 27K
    Retained Earnings
    		 -291.63M -213.63M
    Comprehensive Income
    		 -1.3M -790K
    Shareholders Equity
    		 117.85M 189.97M
    Total Investments
    		 45.67M n/a

    Add to Watchlist